Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to Market the T-SPOT® Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea Oxford Immunotec Global PLC Abingdon, UNITED KINGDOM OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company today announces it has worked with GC MS and MESDIA Co., Ltd. to enter into an MOU to market the research use only T-SPOT
Discovery SARS-CoV-2 kit in South Korea.
«Es gibt verschiedene Aktivitäten, aber es braucht auch Zeit und Verständnis»: Frauenfeld will der Krise trotzen und das Zentrum attraktiver gestalten tagblatt.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tagblatt.ch Daily Mail and Mail on Sunday newspapers.
Oxford Immunotec Global PLC
New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19
New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19
The first survey results reveal physicians seek new diagnostic tools and insights to improve COVID-19 management and patient outcomes
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announces the launch of
100 Physicians Find, a monthly survey that takes the pulse of one hundred medical professionals on the front lines of the COVID-19 pandemic about their perspectives, experiences and needs in the face of this global health crisis.